交易 | 地址 | 数量 |
---|---|---|
a21397...89bbce
|
the-void |
-
12.52850689 LTC
·
955.42 USD
|
a21397...89bbce
|
LfmssD...JG7mdb
|
+
12.52850689 LTC
·
955.42 USD
|
a21397...89bbce
|
script-d69aa3e3947cb3afe7d0268e99d6862f |
+
0 LTC
·
0.00 USD
|
9032c6...bf9dbd
|
LRo1bi...74c35R
|
-
0.25244253 LTC
·
19.25 USD
|
9032c6...bf9dbd
|
LhWjuZ...V6EKbS
|
+
0.25132253 LTC
·
19.16 USD
|
9032c6...bf9dbd
|
the-void |
+
0.00112 LTC
·
0.08 USD
|
f74831...9d12d4
|
LWPPhf...YNX2ZY
|
-
0.002975 LTC
·
0.22 USD
|
f74831...9d12d4
|
LWPPhf...YNX2ZY
|
-
0.003775 LTC
·
0.28 USD
|
f74831...9d12d4
|
LWPPhf...YNX2ZY
|
-
0.00393 LTC
·
0.29 USD
|
f74831...9d12d4
|
LWPPhf...YNX2ZY
|
-
0.00593 LTC
·
0.45 USD
|
MEI Pharma completes $100 million private placement to purchase Litecoin as reserve asset, first publicly traded company to do so.
LD Capital创始人JackYi分析认为,加密货币牛市具有轮动上涨规律,山寨币可能在最后补涨。
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.